<DOC>
	<DOCNO>NCT00623636</DOCNO>
	<brief_summary>This randomize , double blind , placebo control , parallel group study MAP0004 adult migraineurs . Subjects self administer study drug outpatient setting .</brief_summary>
	<brief_title>Phase 3 Study MAP0004 Adult Migraineurs</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Major Male female 18 65 year age . History episodic , acute migraine ( without aura ) onset prior 50 Major Known allergy sensitivity contraindication study drug formulation History chronic pulmonary disease , coronary artery disease ( CAD ) , liver disease , kidney disease , seizures , stroke , major psychiatric condition . Any condition , opinion Investigator , would make subject unsuitable study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Migraine</keyword>
</DOC>